全文获取类型
收费全文 | 262743篇 |
免费 | 20252篇 |
国内免费 | 10495篇 |
专业分类
耳鼻咽喉 | 1408篇 |
儿科学 | 4917篇 |
妇产科学 | 2175篇 |
基础医学 | 31413篇 |
口腔科学 | 3668篇 |
临床医学 | 31140篇 |
内科学 | 30883篇 |
皮肤病学 | 1791篇 |
神经病学 | 24180篇 |
特种医学 | 9869篇 |
外国民族医学 | 25篇 |
外科学 | 28919篇 |
综合类 | 46211篇 |
现状与发展 | 16篇 |
一般理论 | 26篇 |
预防医学 | 15239篇 |
眼科学 | 5270篇 |
药学 | 26714篇 |
107篇 | |
中国医学 | 14421篇 |
肿瘤学 | 15098篇 |
出版年
2024年 | 440篇 |
2023年 | 3128篇 |
2022年 | 5413篇 |
2021年 | 9451篇 |
2020年 | 8555篇 |
2019年 | 7915篇 |
2018年 | 7904篇 |
2017年 | 8398篇 |
2016年 | 8816篇 |
2015年 | 8776篇 |
2014年 | 14718篇 |
2013年 | 16543篇 |
2012年 | 14015篇 |
2011年 | 15754篇 |
2010年 | 13604篇 |
2009年 | 13015篇 |
2008年 | 13174篇 |
2007年 | 14320篇 |
2006年 | 13379篇 |
2005年 | 12702篇 |
2004年 | 10900篇 |
2003年 | 9813篇 |
2002年 | 7756篇 |
2001年 | 7315篇 |
2000年 | 6076篇 |
1999年 | 5438篇 |
1998年 | 4117篇 |
1997年 | 3722篇 |
1996年 | 3497篇 |
1995年 | 3239篇 |
1994年 | 2805篇 |
1993年 | 2422篇 |
1992年 | 2108篇 |
1991年 | 1847篇 |
1990年 | 1532篇 |
1989年 | 1383篇 |
1988年 | 1274篇 |
1987年 | 1020篇 |
1986年 | 813篇 |
1985年 | 986篇 |
1984年 | 918篇 |
1983年 | 587篇 |
1982年 | 701篇 |
1981年 | 651篇 |
1980年 | 533篇 |
1979年 | 410篇 |
1978年 | 319篇 |
1977年 | 271篇 |
1976年 | 292篇 |
1975年 | 174篇 |
排序方式: 共有10000条查询结果,搜索用时 250 毫秒
51.
52.
53.
54.
目的探讨新生儿医用粘胶相关性皮肤损伤(MARSI)危险因素和护理对策。方法选取2016年4月至2018年5月在本院接受治疗的新生儿483例为研究对象,统计其发生MARSI例数和损伤类型,依据是否发生MARSI将患儿分成MARSI组61例和未发生MARSI组422例,记录患儿温箱、胎龄、抢救台、出生体质量、潮湿多汗、蓝光治疗、感染、留置胃管、禁食、经外周静脉置入中心静脉导管(PICC)、水肿及皮肤干燥情况,对影响患儿发生MARSI的因素进行多因素logistic回归分析。结果患儿皮肤受损类型依次为表皮剥脱伤(6.21%)、皮肤撕裂伤(3.73%)、接触性皮炎1.45%。蓝光治疗、留置胃管、出生体质量<2200 g、胎龄<30周及皮肤干燥为患儿发生MARSI的独立危险因素(P<0.05)。结论临床新生儿MARSI发生率较高,且影响因素多,医护人员应采用有针对性护理措施,加强防范,以降低新生儿MARSI的发生率。 相似文献
55.
《Vaccine》2020,38(3):570-577
IntroductionPediatric pneumococcal pneumonia complicated by parapneumonic pleural effusion/empyema (PPE/PE) remains a major concern despite general immunization with pneumococcal conjugate vaccines (PCVs).MethodsIn a nationwide pediatric hospital surveillance study in Germany we identified 584 children <18 years of age with bacteriologically confirmed PPE/PE from October 2010 to June 2018. Streptococcus pneumoniae was identified by culture and/or PCR of blood samples and/or pleural fluid and serotyped.ResultsS. pneumoniae was identified in 256 of 584 (43.8%) children by culture (n = 122) and/or PCR (n = 207). The following pneumococcal serotypes were detected in 114 children: serotype 3 (42.1%), 1 (25.4%), 7F (12.3%), 19A (7.9%), other PCV13 serotypes (4.4%) and non-PCV13 serotypes (7.9%). Between October 2010 and June 2014 serotype 1 (38.1%) and serotype 3 (25.4%) were most prevalent, whereas between July 2014 and June 2018 serotype 3 (62.7%) and non-PCV13 serotypes (15.7%) were dominant. Compared to children with other pneumococcal serotypes, children with serotype 3 associated PPE/PE were younger (median 3.2 years [IQR 2.1–4.3 years] vs. median 5.6 years [IQR 3.8–8.2 years]; p < 0.001) and more frequently admitted to intensive care (43 [89.6%] vs. 48 [73.8%]; p = 0.04). Seventy-six of 114 (66.7%) children with pneumococcal PPE/PE had been vaccinated with pneumococcal vaccines. Thirty-nine of 76 (51.3%) had received a vaccine covering the serotype detected. Thirty of these 39 breakthrough cases were age-appropriately vaccinated with PCV13 and considered vaccine failures, including 26 children with serotype 3, three children with serotype 19A and one child with serotype 1.ConclusionFollowing the introduction of PCV13 in general childhood vaccination we observed a strong emergence of serotype 3 associated PPE/PE in the German pediatric population, including a considerable number of younger children with serotype 3 vaccine breakthrough cases and failures. Future PCVs should not only cover newly emerging serotypes, but also include a more effective component against serotype 3. 相似文献
56.
57.
James Milligan Joseph Lee Matt Smith Lindsay Donaldson Peter Athanasopoulos Kent Bassett-Spiers 《The journal of spinal cord medicine》2020,43(2):223-233
Context: Persons with spinal cord injury (SCI) experience significant challenges when they access primary care and community services.Design: A provincial summit was held to direct research, education, and innovation for primary and community care for SCI.Setting: Toronto, Ontario, Canada.Participants: Key stakeholders (N?=?95) including persons with SCI and caregivers, clinicians from primary care, rehabilitation, and specialized care, researchers, advocacy groups, and policy makers.Methods: A one-day facilitated meeting that included guest speakers, panel discussions and small group discussions was held to generate potential solutions to current issues related to SCI care and to foster collaborative relationships to advance care for SCI. Perspectives on SCI management were shared by primary care, neurosurgery, rehabilitation, and members of the SCI communityOutcome Measures: Discussions were focused on five domains: knowledge translation and dissemination, application of best practices, communication, research, and patient service accessibility.Results: Summit participants identified issues and prioritized solutions to improve primary and community care including the creation of a network of key stakeholders to enable knowledge creation and dissemination; an online repository of SCI resources, integrated health records, and a clinical network for SCI care; development and implementation of strategies to improve care transitions across sectors; implementation of effective care models and improved access to services; and utilization of empowerment frameworks to support self-management.Conclusions: This summit identified priorities for further collaborative efforts to advance SCI primary and community care and will inform the development of a provincial SCI strategy aimed at improving the system of care for SCI. 相似文献
58.
59.
Interstitial cystitis/bladder pain syndrome (IC/BPS) and vulvodynia are chronic pain syndromes that appear to be intertwined from the perspectives of embryology, pathology and epidemiology. These associations may account for similar responses to various therapies. 相似文献
60.